World Lifestyler
  • Art & Culture
    • Architecture
    • Art & Exhibitions
    • Books
    • Design
    • Film & Music
  • Competitions
    • Dining Experiences
    • Hotel Stays
    • Luxury Experiences
    • Product Giveaways
    • Reader Exclusives
    • Travel Giveaways
  • Food & Drink
    • Chefs
    • Coffee Culture
    • Food Destinations
    • Recipes
    • Restaurants
    • Wine & Spirits
  • Lifestyle
    • Design
    • Fashion
    • Health & Wellbeing
    • Homes & Property
    • Love & Romance
  • People
    • Creatives
    • Entrepreneurs
    • Icons
    • Interviews
    • Profiles
    • Rising Talent
  • Travel
    • Adventure & Experience Travel
    • City Guides
    • Destinations
    • Hotels
    • Secret Spots
    • Travel Trends
  • Art & Culture
    • Architecture
    • Art & Exhibitions
    • Books
    • Design
    • Film & Music
  • Competitions
    • Dining Experiences
    • Hotel Stays
    • Luxury Experiences
    • Product Giveaways
    • Reader Exclusives
    • Travel Giveaways
  • Food & Drink
    • Chefs
    • Coffee Culture
    • Food Destinations
    • Recipes
    • Restaurants
    • Wine & Spirits
  • Lifestyle
    • Design
    • Fashion
    • Health & Wellbeing
    • Homes & Property
    • Love & Romance
  • People
    • Creatives
    • Entrepreneurs
    • Icons
    • Interviews
    • Profiles
    • Rising Talent
  • Travel
    • Adventure & Experience Travel
    • City Guides
    • Destinations
    • Hotels
    • Secret Spots
    • Travel Trends
No Result
View All Result
WORLD LIFESTYLER
No Result
View All Result
Home Press Releases Press Releases - Lifestyle

Invesco Ltd. – Invesco Ltd: Form 8.3 – Advanced Medical Solutions Group PLC; Public dealing disclosure

Cision PR Newswire by Cision PR Newswire
May 14, 2026
in Press Releases - Lifestyle
Reading Time: 31 mins read
0
Share on FacebookShare on Twitter


FORM 8.3


PUBLIC DEALING DISCLOSURE BY


A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE


Rule 8.3 of the Takeover Code (the “Code”)

** amendment has been made to remove the wording of a discretionary holding below section 2A , as this is not relevant **


1.


KEY INFORMATION

 


(a)


Full name of discloser:

Invesco Ltd.


(b)


Owner or controller of interests and short positions disclosed, if different from 1(a):


The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

 


(c)


Name of offeror/offeree in relation to whose relevant securities this form relates:


Use a separate form for each offeror/offeree

Advanced Medical Solutions Group plc


(d)


If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

 


(e)


Date position held/dealing undertaken:


For an opening position disclosure, state the latest practicable date prior to the disclosure

13.05.2026

 


(f)


In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?


If it is a cash offer or possible cash offer, state “N/A”

N/A

 

 


2.


POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 


If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.


(a)


Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 


Class of relevant security:


5p ordinary GB0004536594, LEI: 213800HJP6OWOSZI1L74


 


Interests


Short Positions


 


Number


%


Number


%


(1)


Relevant securities owned and/or controlled:

4,484,726

2.03

 

 


(2)


Cash-settled derivatives:

 

 

 

 


(3)


Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 


 


Total

4,484,726

2.03

 

 

 


 

 


All interests and all short positions should be disclosed.


Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

 


(b)


Rights to subscribe for new securities (including directors’ and other employee options)

 


Class of relevant security in relation to which subscription right exists:

 


Details, including nature of the rights concerned and relevant percentages:

 

 


3.


DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 


Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.


The currency of all prices and other monetary amounts should be stated.


(a)


Purchases and sales

 


Class of relevant security


Purchase/sale


Number of securities


Price per unit

5p ordinary GB0004536594

Sale

522,428

2.46
 
GBP

 


(b)


Cash-settled derivative transactions

 


Class of relevant security


Product description


e.g. CFD


Nature of dealing


e.g. opening/closing a long/short position, increasing/reducing a long/short position


Number of reference securities


Price per unit

 

 

 

 

 

 


(c)


Stock-settled derivative transactions (including options)

 


(i)


Writing, selling, purchasing or varying

 


Class of relevant security


Product description


e.g. call option


Writing, purchasing, selling, varying etc.


Number of securities to which option relates


Exercise price per unit


Type


e.g. American, European etc.


Expiry date


Option money paid/ received per unit

 

 

 

 

 

 

 

 

 


(ii)


Exercise

 


Class of relevant security


Product description


e.g. call option


Exercising/ exercised against


Number of securities


Exercise price per unit

 

 

 

 

 

 


(d)


Other dealings (including subscribing for new securities)

 


Class of relevant security


Nature of dealing


e.g. subscription, conversion


Details


Price per unit (if applicable)

 

 

 

 

 


4.


OTHER INFORMATION

 


(a)


Indemnity and other dealing arrangements

 


Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:


Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

None

 


(b)


Agreements, arrangements, or understandings relating to options or derivatives

 


Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:


(i) the voting rights of any relevant securities under any option; or


(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:


If there are no such agreements, arrangements or understandings, state “none”

None

 

 


Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 


Date of disclosure

14.05.2026


Contact name

Philippa Holmes


Telephone number

+441491417447

 


Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.


The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.


The Code can be viewed on the Panel’s website at



www.thetakeoverpanel.org.uk



.



Cision PR Newswire

Cision PR Newswire

Related Posts

Allegheny Health Network’s Cardiovascular Institute Sees Positive Outcomes from Groundbreaking Therapy for Treatment-Resistant Hypertension

May 14, 2026

Felicitysolar Deepens European Market Presence Through Authorized Partnerships in the Netherlands and Spain

May 14, 2026

Resurge Therapeutics Announces Positive Clinical Results from Two Studies of Its Intraprostatic Drug Elution Platform for Benign Prostatic Hyperplasia (BPH) at AUA 2026

May 14, 2026

BCE to participate in the J.P. Morgan 2026 Global Technology, Media and Communications Conference in Boston

May 14, 2026

CryptoSlots Celebrates 8th Birthday with VR Slots, New Game Launches and Month-Long Promotions

May 14, 2026

Bell names construction partners for 300 MW Saskatchewan AI Fabric facility and announces long-term partnership with Bird Construction

May 14, 2026

Popular News

  • SBC, IAGR & IMGL combine for three-year regulatory education project

    0 shares
    Share 0 Tweet 0
  • DeFi Technologies Appoints Russell Starr as Strategic Advisor

    0 shares
    Share 0 Tweet 0
  • MOHEGAN ANNOUNCES SECOND QUARTER FISCAL 2026 OPERATING RESULTS

    0 shares
    Share 0 Tweet 0
  • Allegheny Health Network’s Cardiovascular Institute Sees Positive Outcomes from Groundbreaking Therapy for Treatment-Resistant Hypertension

    0 shares
    Share 0 Tweet 0
  • Wingstop Debuts ‘House of Flavor’ Fan Experience in North America for the First Time

    0 shares
    Share 0 Tweet 0

About & Contact

  • About Us
  • Branding Style Guide
  • Contact Us
  • Help Centre
  • Media Kit
  • Site Map

Explore Content

  • Events
  • Newsletter
  • Press Releases
  • Topics

Legal & Privacy

  • Advertiser & Partner Policy
  • Communications & Newsletter Policy
  • Contributor Agreement
  • Copyright Policy
  • Privacy Policy
  • Prohibited Content Policy
  • Terms of Service

Tiny Media Brands

  • Silicon Valleys Journal
  • The AI Journal
  • The City Banker
  • The Wall Street Banker
  • World Lifestyler

© 2025 World Lifestyler

No Result
View All Result
  • Home

© 2025 World Lifestyler